CELECOXIB; TRAMADOL HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for celecoxib; tramadol hydrochloride and what is the scope of freedom to operate?
Celecoxib; tramadol hydrochloride
is the generic ingredient in one branded drug marketed by Kowa Pharms and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Celecoxib; tramadol hydrochloride has one hundred and five patent family members in thirty-five countries.
One supplier is listed for this compound.
Summary for CELECOXIB; TRAMADOL HYDROCHLORIDE
| International Patents: | 105 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 22 |
| DailyMed Link: | CELECOXIB; TRAMADOL HYDROCHLORIDE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for CELECOXIB; TRAMADOL HYDROCHLORIDE
Generic Entry Date for CELECOXIB; TRAMADOL HYDROCHLORIDE*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for CELECOXIB; TRAMADOL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Henry Ford Health System | Phase 4 |
| Addpharma Inc. | Phase 1 |
| University of Western Ontario, Canada | Phase 4 |
Pharmacology for CELECOXIB; TRAMADOL HYDROCHLORIDE
| Drug Class | Nonsteroidal Anti-inflammatory Drug Opioid Agonist |
| Mechanism of Action | Cyclooxygenase Inhibitors Full Opioid Agonists |
US Patents and Regulatory Information for CELECOXIB; TRAMADOL HYDROCHLORIDE
International Patents for CELECOXIB; TRAMADOL HYDROCHLORIDE
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| South Korea | 20120099212 | CO-CRYSTALS OF TRAMADOL AND COXIBS | ⤷ Try a Trial |
| Mexico | 2012014087 | COMPOSICIONES FARMACEUTICAS DE CO- CRISTALES DE TRAMADOL Y COXIBS. (PHARMACEUTICAL COMPOSITIONS OF CO-CRYSTALS OF TRAMADOL AND COXIBS.) | ⤷ Try a Trial |
| European Patent Office | 2488169 | CO-CRISTAUX DE TRAMADOL ET NSAID (CO-CRYSTALS OF TRAMADOL AND COXIBS) | ⤷ Try a Trial |
| Australia | 2011260608 | Pharmaceutical compositions of co-crystals of tramadol and coxibs | ⤷ Try a Trial |
| Denmark | 2488169 | ⤷ Try a Trial | |
| Slovenia | 2575778 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CELECOXIB; TRAMADOL HYDROCHLORIDE
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0731795 | 10075033 | Germany | ⤷ Try a Trial | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
